BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 27586010)

  • 1. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
    Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
    Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of in vitro lymphocyte radiosensitivity and gene expression with late normal tissue reactions following curative radiotherapy for breast cancer.
    Finnon P; Kabacik S; MacKay A; Raffy C; A'Hern R; Owen R; Badie C; Yarnold J; Bouffler S
    Radiother Oncol; 2012 Dec; 105(3):329-36. PubMed ID: 23157981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
    Barber JB; Burrill W; Spreadborough AR; Levine E; Warren C; Kiltie AE; Roberts SA; Scott D
    Radiother Oncol; 2000 May; 55(2):179-86. PubMed ID: 10799730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy.
    Chua ML; Horn S; Somaiah N; Davies S; Gothard L; A'Hern R; Yarnold J; Rothkamm K
    Radiat Environ Biophys; 2014 May; 53(2):355-64. PubMed ID: 24622963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte telomere length correlates with in vitro radiosensitivity in breast cancer cases but is not predictive of acute normal tissue reactions to radiotherapy.
    Iwasaki T; Robertson N; Tsigani T; Finnon P; Scott D; Levine E; Badie C; Bouffler S
    Int J Radiat Biol; 2008 Apr; 84(4):277-84. PubMed ID: 18386193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of late normal tissue complications in RT treated gynaecological cancer patients: potential of the gamma-H2AX foci assay and association with chromosomal radiosensitivity.
    Werbrouck J; De Ruyck K; Beels L; Vral A; Van Eijkeren M; De Neve W; Thierens H
    Oncol Rep; 2010 Feb; 23(2):571-8. PubMed ID: 20043123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
    Bentzen SM; Overgaard M; Overgaard J
    Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.
    Dunst J; Neubauer S; Becker A; Gebhart E
    Strahlenther Onkol; 1998 Oct; 174(10):510-6. PubMed ID: 9810318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
    López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
    Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA repair foci and late apoptosis/necrosis in peripheral blood lymphocytes of breast cancer patients undergoing radiotherapy.
    Marková E; Somsedíková A; Vasilyev S; Pobijaková M; Lacková A; Lukačko P; Belyaev I
    Int J Radiat Biol; 2015; 91(12):934-45. PubMed ID: 26537244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.
    Borgmann K; Hoeller U; Nowack S; Bernhard M; Röper B; Brackrock S; Petersen C; Szymczak S; Ziegler A; Feyer P; Alberti W; Dikomey E
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):256-64. PubMed ID: 18406889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
    Dunst J; Gebhart E; Neubauer S
    Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of radiation-induced toxicity by in vitro radiosensitivity of lymphocytes in prostate cancer patients.
    Pinkawa M; Brzozowska K; Kriehuber R; Eble MJ; Schmitz S
    Future Oncol; 2016 Mar; 12(5):617-24. PubMed ID: 26806671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes.
    De Ruyck K; Van Eijkeren M; Claes K; Morthier R; De Paepe A; Vral A; De Ridder L; Thierens H
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1140-9. PubMed ID: 15990020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy.
    Johansen J; Bentzen SM; Overgaard J; Overgaard M
    Radiother Oncol; 1996 Aug; 40(2):101-9. PubMed ID: 8884963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation.
    Jones LA; Scott D; Cowan R; Roberts SA
    Int J Radiat Biol; 1995 May; 67(5):519-28. PubMed ID: 7775827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays.
    Djuzenova CS; Mühl B; Fehn M; Oppitz U; Müller B; Flentje M
    Br J Cancer; 2006 Apr; 94(8):1194-203. PubMed ID: 16538220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients.
    Geara FB; Peters LJ; Ang KK; Wike JL; Brock WA
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1173-9. PubMed ID: 8262844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation.
    Hepel JT; Tokita M; MacAusland SG; Evans SB; Hiatt JR; Price LL; DiPetrillo T; Wazer DE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1290-6. PubMed ID: 19395195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
    Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM
    Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.